Advisor Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Advisor Group’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$7K	Buy	+800	New	+$6.24K	﹤0.01%	4549
2019 Q3	–	Sell	-14	Closed	–	–	5517
2019 Q2	$0	Buy	+14	New	+$121	﹤0.01%	5457
2018 Q4	–	Sell	-100	Closed	-$1K	–	5324
2018 Q3	$1K	Buy	+100	New	+$1.35K	﹤0.01%	5037
2017 Q1	–	Sell	-337	Closed	-$1K	–	4853
2016 Q4	$1K	Buy	+337	New	+$1.63K	﹤0.01%	4432

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Advisor Group's KIN Position: Q4 2019 in Review

Advisor Group opened a new position in Kindred Biosciences, Inc. (KIN) in Q4 2019: 800 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #4549 among its holdings. This is a return to the name: Advisor Group previously reported a position in KIN as recently as Q2 2019.

Advisor Group first reported a position in KIN in Q4 2016 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold KIN as of Q4 2019.

Advisor Group held 800 shares of Kindred Biosciences, Inc. worth $7K as of Q4 2019.
Kindred Biosciences, Inc. was a new Advisor Group position in Q4 2019.
Kindred Biosciences, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4549 holding.
Advisor Group first reported a position in Kindred Biosciences, Inc. in Q4 2016 and has held it in 4 quarters since.
75 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.